Balsalazide and azathiprine or 6-mercaptopurine: evidence for a potentially serious drug interaction.
P W
PW
Lowry
C L
CL
Szumlanski
R M
RM
Weinshilboum
W J
WJ
Sandborn
D000636:Aminosalicylic Acids / Q000009:adverse effects / Q000627:therapeutic use*; D000897:Anti-Ulcer Agents / Q000009:adverse effects / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D015122:Mercaptopurine / Q000009:adverse effects / Q000627:therapeutic use*; D019804:Mesalamine; D010659:Phenylhydrazines
D000636:Aminosalicylic Acids; D000897:Anti-Ulcer Agents; D018501:Antirheumatic Agents; D010659:Phenylhydrazines; D019804:Mesalamine; D015122:Mercaptopurine; D001379:Azathioprine; C038637:balsalazide